Y-mAbs Therapeutics Inc (YMAB)
10.10
-0.44
(-4.17%)
USD |
NASDAQ |
Nov 21, 16:00
9.95
-0.15
(-1.49%)
Pre-Market: 08:10
Y-mAbs Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.28 |
| Beta (5Y) | 0.6777 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.20% |
| Historical Sharpe Ratio (5Y) | -0.1737 |
| Historical Sortino (5Y) | -0.3234 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.61% |